NealPatelMD

PubMed

• 2 citations
  Real-world cure rates for hepatitis C virus treatments that include simeprevir and/or sofosbuvir are comparable to clinical trial results.
  Kian Bichoupan, Neeta Tandon, James F. Crismale, Joshua Hartman, David Del Bello, Neal Patel, Sweta Chekuri, Alyson Harty, Michel Ng, Keith Sigel, Meena B. Bansal, Pri...> ;World Journal of Virology. 2017 Nov 12
• 1 citations
  Factors associated with success of telaprevir- and boceprevir-based triple therapy for hepatitis C virus infection
  Kian Bichoupan, Neeta Tandon, Valérie Martel-Laferrière, Neal Patel, David H. Sachs, Michel Ng, Emily A. Schonfeld, Alexis Pappas, James F. Crismale, A. Stivala, Vikto...> ;World Journal of Hepatology. 2017 Apr 18
• 2 citations
  High baseline bilirubin and low albumin predict liver decompensation and serious adverse events in HCV-infected patients treated with sofosbuvir-containing regimens
  Ponni V. Perumalswami, Neal Patel, Kian Bichoupan, L. Ku, R. Yalamanchili, Alyson Harty, David Motamed, Viktoriya Khaitova, Charissa Chang, Priya Grewal, Lawrence U Li...> ;Journal of Viral Hepatitis. 2016 Sep 1
• 3 citations
  Hepatic decompensation/serious adverse events in post-liver transplantation recipients on sofosbuvir for recurrent hepatitis C virus.
  , , , , , , , , , , , , , , , , , , , , , , , > ;World Journal of Gastroenterology. 2016 Mar 7
• 3 citations
  Re-re-treatment of hepatitis C virus: Eight patients who relapsed twice after direct-acting-antiviral drugs
  Joshua Hartman, Kian Bichoupan, Neal Patel, Sweta Chekuri, Alyson Harty, Douglas T. Dieterich, Ponni V. Perumalswami, Andrea D. Branch> ;World Journal of Gastroenterology. 2015 Nov 21
• Join now to see all